Skip to main content
HeartCited

Quercetin para Atherosclerosis

D Pesquisa Existem apenas investigaciones preliminares (estudos laboratoriais, relatórios de casos).

In vitro evidence for PCSK9 inhibition and reduced foam cell formation. Limited human data on atherosclerosis endpoints specifically.

D

Conclusão

In vitro evidence for PCSK9 inhibition and reduced foam cell formation. Limited human data on atherosclerosis endpoints specifically.

Key Statistics

2

Estudos

100

Participantes

↑

Positive

D

Nota

Referenced Papers

Exploration of Potential Targets and Molecular Mechanisms of the Yiqi Jianpi Tongqiao Formula in Treating Allergic Rhinitis Mouse Model based … Other
Current computer-aided drug … 2025 2 citações
Dual Modulation of Canonical and Non-canonical TGF-β/ROS/Erk1/2 Pathways: Synergistic Activation of Nrf-2 and Antioxidant Enzymes (SOD1, GPx, HO-1) by Quercetin … Other
Iranian journal of … 2024 4 citações
Using herbal medicine to target the "microbiota-metabolism-immunity" axis as possible therapy for cardiovascular disease. Review
Pharmacological research 2019 31 citações
Dietary Polyphenols in the Prevention of Stroke. Review
Oxidative medicine and … 2017 87 citações

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

general:
500-1,000 mg/day
bloodpressuresupport:
500-730 mg/day

Limite superior: Not formally established; up to 1,000 mg/day used in clinical trials

Melhor horário: With meals; vitamin C co-supplementation may enhance bioavailability

Safety & Side Effects

Efeitos Colaterais Relatados

  • ⚠ Generally well-tolerated
  • ⚠ Headache (rare)
  • ⚠ Mild gastrointestinal discomfort
  • ⚠ Tingling in extremities (rare, high doses)

Interações Conhecidas

  • ● Antibiotics (quinolones — may reduce efficacy)
  • ● Cyclosporine (may increase blood levels)
  • ● Anticoagulants (may have mild antiplatelet effect)
  • ● Blood pressure medications (additive effect)

Ingestão máxima tolerável: Not formally established; up to 1,000 mg/day used in clinical trials

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does Quercetin help with Atherosclerosis?
Based on 2 studies with 100 participants, there is preliminary evidence that needs more research that Quercetin may support Atherosclerosis management. Our evidence grade is D (Very Early Research).
How much Quercetin should I take for Atherosclerosis?
Studies have used various dosages. A commonly studied range is 500-1,000 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Quercetin?
Reported side effects may include Generally well-tolerated, Headache (rare), Mild gastrointestinal discomfort, Tingling in extremities (rare, high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Quercetin and Atherosclerosis?
We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

Quercetin para outras condições

High Blood Pressure (Hypertension) B

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  










  
References

  
    
    
    
  1. 
      [1]
      Sihong Huang et al..
      Curr Comput Aided Drug Des.
      2025.
      Exploration of Potential Targets and Molecular Mechanisms of the Yiqi Jianpi Tongqiao Formula in Treating Allergic Rhinitis Mouse Model based …
      doi:10.2174/0115734099299714240516160158
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Masoumeh Shamsi et al..
      Iran J Pharm Res.
      2024.
      Dual Modulation of Canonical and Non-canonical TGF-β/ROS/Erk1/2 Pathways: Synergistic Activation of Nrf-2 and Antioxidant Enzymes (SOD1, GPx, HO-1) by Quercetin …
      doi:10.5812/ijpr-151428
      PubMed
    
    3. 
    
    
  3. 
      [3]
      Wang Anlu et al..
      Pharmacol Res.
      2019.
      Using herbal medicine to target the "microbiota-metabolism-immunity" axis as possible therapy for cardiovascular disease.
      doi:10.1016/j.phrs.2019.02.018
      PubMed
    
    4. 
    
    
  4. 
      [4]
      A Tressera-Rimbau et al..
      Oxid Med Cell Longev.
      2017.
      Dietary Polyphenols in the Prevention of Stroke.
      doi:10.1155/2017/7467962
      PubMed
    
    5. 
    
  















    

        Aviso Legal da FDA:
        Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.